Made available in DSpace on 2016-05-02T13:54:48Z (GMT). No. of bitstreams: 1 AdrianaPoncianoFernandes-dissertacao.pdf: 757676 bytes, checksum: 9e7b2d453d791c3e8b207f675e650f36 (MD5) Previous issue date: 2008-10-13 / This study analyzed the effects of the hydroalcoholic extract of Pyrostegia venusta, popularly known as cipó-de-são-joão , on various types of Gram negative and Gram positive bacteria, and on yeasts. It also evaluated the effects of the extract on the growth and cell differentiation in Herpetomonas samuelpessoai in vitro , and the in vivo mutagenic effect by the micronucleus test. The antimicrobial activity of the extract was evaluated by two methods: agar diffusion test, and tube dilution test. The growth and cell differentiation of H. samuelpessoai occurred in chemically defined medium after incubation at 28°C, for 48 hours. Growth was calculated by cell count in a Neubauer chamber, and differentiation was measured by observing cells stained by the panoptic method to calculate the percentages of the pro-, para- and opistomastigote forms. To determine the LD 50, groups of female albino Swiss mice received a single oral dose of different extract concentrations (300 mg/kg and 2000 mg/kg). For mutagenic evaluation, Swiss albino mice, aged approximately12 weeks, were used. Each trial was carried out in five groups of animals, each group consisting of 3 males and 3 females: negative control (0.9% NaCl); positive control (50 mg/kg of ENU) treatments 1, 2 and 3 (1000, 1500 and 2000 mg/kg of extract, respectively). The micronucleus test in mouse bone marrow erythrocytes was done 24 and 28 hours after treatment. The polychromatic erythrocytes (PCEs) were observed through an optical microscope and counted with the help of a digital cell counter. The results showed that the hydroalcoholic extract of Pyrostegia venusta leaves at the concentrations of 72.6 mg/mL and 145.2 mg/mL had no antimicrobial activity on the 19 strains of bacteria and yeasts tested. With regard to LD50, the extract did not show median lethal dose at the concentrations of 300 mg/kg and 2000 mg/kg. The micronucleus test showed statistically significant differences in the number/percentage index of micronucleated PCEs between the positive control group (ENU 50mg/kg) and negative control (0.9% NaCl), and positive control and extract treatments. But these differences were not observed either between the negative controls and the extract-treated group, or between the sexes and times of treatment (24 hr-48hr), thus suggesting that the hydroalcoholic extract of P. venusta leaves does not exhibit either clastogenic or aneugenic potentials. / Este estudo teve por objetivos analisar os efeitos do extrato hidroalcoólico de Pyrostegia venusta, conhecida popularmente como cipó-de-são-joão, sobre diversos tipos de bactérias Gram-negativas e Gram-positivas e também sobre leveduras, além de analisar seu efeito no crescimento e diferenciação celular em Herpetomonas samuelpessoai in vitro e mutagênico in vivo , através do Teste do Micronúcleo. A atividade antimicrobiana do extrato foi verificada por dois métodos: teste de difusão em ágar e teste de diluição em tubo. Os experimentos de crescimento e diferenciação celular de H. samuelpessoai foram realizados em meio quimicamente definido, após incubação a 28 °C, por 48 horas, sendo o crescimento estimado pela contagem das células em câmara de Neubauer e a diferenciação pela observação das células coradas pelo método Panótico em microscopia óptica, objetivando estimar os percentuais de formas pró, para e opistomastigota. Para a determinação da DL 50 foram utilizados grupos de camundongos Swiss albinos fêmeas que receberam, por via oral, dose única de diferentes concentrações do extrato (300 e 2000 mg/Kg). Para a avaliação mutagênica foram utilizados camundongos Swiss albinos, com idade aproximada de 12 semanas. Cada ensaio foi realizado empregando-se cinco grupos de animais, cada grupo constituído por 3 machos e 3 fêmeas, sendo assim tratados: controle negativo (NaCl 0,9%); controle positivo (50 mg/kg ENU); tratamento 1, 2 e 3 (1000, 1500 e 2000mg/Kg do extrato, respectivamente). O teste do micronúcleo em eritrócitos da medula óssea de camundongos foi realizado 24 e 48 horas após o tratamento, e os eritrócitos policromáticos (PCEs) foram observados em microscopia óptica e contados com o auxílio de um contador de células digital. Os resultados evidenciaram que o extrato hidroalcoólico da folha de Pyrostegia venusta, nas concentrações testadas (72,6 mg/mL e 145,2 mg/mL), não possui atividade antimicrobiana para as dezenove cepas testadas de bactérias e fungos. No que se refere à DL50, o extrato não apresentou dose letal média nas concentrações testadas de 300mg/kg e 2000mg/kg. Ao teste de micronúcleo, os resultados revelaram diferenças estatísticas significativas do número/índice percentual de PCEs micronucleados entre o grupo de animais do controle positivo (ENU 50mg/Kg) e controle negativo (NaCl 0,9%), bem como controle positivo e tratamentos com o extrato. Entretanto, essas diferenças não foram observadas entre o grupo de animais do controle negativo e o grupo de animais tratados com o extrato e, ainda, entre os sexos e os tempos de tratamento (24-48h), sugerindo que o extrato hidroalcoólico de folhas de P. venusta não apresenta potencial clastogênico e/ou aneugênico

A proteína eIF5A apresenta um resíduo exclusivo de aminoácido chamado hipusina formado por modificação pós-traducional envolvendo espermidina como substrato. Neste estudo, observamos que a expressão de eIF5A é intensificada ao longo da diferenciação de células-tronco progenitoras de fibras musculares (células satélites) e que a inibição da hipusinação com GC7 bloqueia a diferenciação. Associado a esse bloqueio encontramos aumento do consumo de glicose e produção de lactato, diminuição da descarboxilação de glicose e palmitato, redução da proliferação celular e alteração do perfil traducional, efeitos que podem estar envolvidos na inibição do programa de diferenciação. Em seguida, o músculo tibial anterior de ratos foram criolesados e após severa supressão da expressão de eIF5A (período agudo de lesão) a mesma foi retomada ao longo da regeneração, chegando a quantidades superiores ao encontrado em músculos não lesados. Verificamos que a L-arginina, um supressor parcial do fenótipo distrófico e precursor de espermidina, reverte parcialmente o efeito de GC7. / eIF5A protein contains an exclusive amino acid residue named hypusine produced by a post-translational modification involving spermidine as substrate. In this study, we observed that eIF5A expression is raised during muscle fiber stem cells (satellite cells) differentiation and the hypusination inhibition by GC7 abolished the differentiation process. In association with this blockage, an increase in glucose consumption and lactate production, a decrease in glucose and palmitate decarboxylation, a reduction in cell proliferation and an alteration in translational profile were observed. These changes may be involved in the inhibition of the differentiation induced by GC7. The rat tibialis anterior muscle was injured and a marked reduction of eIF5A expression (acute injury period) was found. The expression of eIF5A was reestablished during regeneration, reaching higher levels than that observed in non injured muscle. We also verified that L-arginine, a partial suppressor of muscle dystrophic phenotype condition and precursor of spermidine, partially abolished the GC7 effects.

BACKGROUND: Bone remodeling relies on the tightly regulated interplay between bone forming osteoblasts and bone digesting osteoclasts. Several studies have now described the molecular mechanisms by which osteoblasts control osteoclastogenesis and bone degradation. It is currently unclear whether osteoclasts can influence bone rebuilding. METHODOLOGY/PRINCIPAL FINDINGS: Using in vitro cell systems, we show here that mature osteoclasts, but not their precursors, secrete chemotactic factors recognized by both mature osteoblasts and their precursors. Several growth factors whose expression is upregulated during osteoclastogenesis were identified by DNA microarrays as candidates mediating osteoblast chemotaxis. Our subsequent functional analyses demonstrate that mature osteoclasts, whose platelet-derived growth factor bb (PDGF-bb) expression is reduced by siRNAs, exhibit a reduced capability of attracting osteoblasts. Conversely, osteoblasts whose platelet-derived growth factor receptor beta (PDGFR-beta) expression is reduced by siRNAs exhibit a lower capability of responding to chemotactic factors secreted by osteoclasts. CONCLUSIONS/SIGNIFICANCE: We conclude that, in vitro mature osteoclasts control osteoblast chemotaxis via PDGF-bb/PDGFR-beta signaling. This may provide one key mechanism by which osteoclasts control bone formation in vivo.

Bone marrow mesenchymal stromal cells (BM MSCs) represent a heterogeneous population of progenitors with potential for generation of skeletal tissues. However the identity of BM MSC subpopulations is poorly defined mainly due to the absence of specific markers allowing in situ localization of those cells and isolation of pure cell types. Here, we aimed at characterization of surface markers in mouse BM MSCs and in their subsets with distinct differentiation potential. Using conditionally immortalized BM MSCs we performed a screening with 176 antibodies and high-throughput flow cytometry, and found 33 markers expressed in MSCs, and among them 3 were novel for MSCs and 13 have not been reported for MSCs from mice. Furthermore, we obtained clonally derived MSC subpopulations and identified bipotential progenitors capable for osteo- and adipogenic differentiation, as well as monopotential osteogenic and adipogenic clones, and thus confirmed heterogeneity of MSCs. We found that expression of CD200 was characteristic for the clones with osteogenic potential, whereas SSEA4 marked adipogenic progenitors lacking osteogenic capacity, and CD140a was expressed in adipogenic cells independently of their efficiency for osteogenesis. We confirmed our observations in cell sorting experiments and further investigated the expression of those markers during the course of differentiation. Thus, our findings provide to our knowledge the most comprehensive characterization of surface antigens expression in mouse BM MSCs to date, and suggest CD200, SSEA4 and CD140a as markers differentially expressed in distinct types of MSC progenitors.

A goal in human embryonic stem cell (hESC) research is the faithful differentiation to given cell types such as neural lineages. During embryonic development, a basement membrane surrounds the neural plate that forms a tight, apico-basolaterally polarized epithelium before closing to form a neural tube with a single lumen. Here we show that the three-dimensional epithelial cyst culture of hESCs in Matrigel combined with neural induction results in a quantitative conversion into neuroepithelial cysts containing a single lumen. Cells attain a defined neuroepithelial identity by 5 days. The neuroepithelial cysts naturally generate retinal epithelium, in part due to IGF-1/insulin signaling. We demonstrate the utility of this epithelial culture approach by achieving a quantitative production of retinal pigment epithelial (RPE) cells from hESCs within 30 days. Direct transplantation of this RPE into a rat model of retinal degeneration without any selection or expansion of the cells results in the formation of a donor-derived RPE monolayer that rescues photoreceptor cells. The cyst method for neuroepithelial differentiation of pluripotent stem cells is not only of importance for RPE generation but will also be relevant to the production of other neuronal cell types and for reconstituting complex patterning events from three-dimensional neuroepithelia.

Das Chemokine SDF-1α und sein Rezeptor CXCR4 sind in eine Vielzahl biologischer Prozesse, wie der Organogenese, der Hämatopoese und der Immunantwort involviert. Die Entdeckung des alternativen SDF-1α-Rezeptors CXCR7 bewirkte eine erneute Untersuchung der Funktion des SDF-1-Systems in diesen Vorgängen. CXCR7 ist in der Lage, je nach Gewebe- oder Zelltyp, als \'Scavenger\'-Rezeptor, Modulator des CXCR4 oder selbstständig aktiver Rezeptor zu agieren. In dieser Arbeit wurde untersucht, inwiefern beide Rezeptoren im Verlauf der Entwicklung der Muskulatur exprimiert werden, welche Aufgabe sie dabei übernehmen und ob sich Rückschlüsse auf die Muskelregeneration daraus ableiten lassen. Hierfür erfolgten in vitro-Untersuchungen an C2C12-Zellen und die anschließende Analyse der Expression von CXCR4, CXCR7 und SDF-1α in der sich entwickelnden Gliedmaßenmuskulatur von Wildtyp- und mdx-Mäusen. Die Untersuchung von C2C12-Zellen zeigte in allen Differenzierungsstadien eine detektierbare Menge von CXCR4 und eine zunehmende Expression des CXCR7. Die Behandlung der Zellen mit SDF-1α führte zu einer Phosphorylierung von Erk1/2 und PKCζ/λ und hemmte gleichzeitig deren Differenzierung. Nach einer Blockierung des CXCR4 mit seinem pharmakologischen Antagonist AMD3100 oder nach Hemmung der Expression durch spezifische siRNA blieb die Aktivierung des Signalweges aus und der hemmende Einfluss des SDF-1α auf die Differenzierung verschwand vollständig. Im Gegensatz dazu blieben nach der pharmakologischen Blockierung oder durch siRNA vermittelten Expressionshemmung des CXCR7 alle SDF-1α induzierten Effekte vollständig erhalten. Eine Untersuchung des Signalweges am dritten Tag der Differenzierung zeigte keine Aktivierung von Erk1/2. Ebenso blieb Erk1/2 nach einer Hemmung der Expression des CXCR4 unphosphoryliert. Im Gegensatz dazu fand nach einer Hemmung der Expression des CXCR7 mit spezifischer siRNA erneut eine Aktivierung des Signalweges statt. Weiterhin konnte in vivo festgestellt werden, dass die Expression des CXCR4 in der Muskulatur während der embryonalen Entwicklung am höchsten ist und bereits kurz nach der Geburt stark abnimmt, wenn die sekundäre Muskelentwicklung abgeschlossen ist. Die Expression des CXCR7 hingegen steigt perinatal an und bleibt bis zum Erwachsenenalter bestehen. Zusammengefasst zeigen diese Ergebnisse, dass CXCR4 aktiv das Signalgeschehen von SDF-1α in der Myogenese vermittelt und somit zur Differenzierungshemmung von Myoblasten beiträgt. CXCR7 hingegen wirkt als passiver SDF-1α-Scavenger und induziert somit durch eine Modulierung der extrazellulären SDF-1α-Konzentration die Differenzierung. In Übereinstimmung mit der Rolle des SDF-1α-Systems bei der Muskelentwicklung, konnte eine kontinuierliche SDF-1α- Expression im Bindegewebe um pränatale und im Endomysium von postnatalen und adulten Muskelfasern festgestellt werden. Diese SDF-1α-Expression stieg ebenso wie die CXCR4-Expression bei der Analyse der Muskulatur von dystrophin-defizienten Mäusen an und zeigte somit, dass dieses System auch für die Proliferation von Muskelvorläuferzellen in der regenerativen Muskulatur eine wichtige Rolle spielt. Bemerkenswerter Weise hatte diese Muskeldystrophie keinen Einfluss auf die Expression des CXCR7 und beeinflusst vermutlich dessen Funktion über einen anderen Mechanismus. Durch die offensichtlich enge Kontrolle von Muskelentwicklung und Regeneration durch CXCR4, CXCR7 und deren Liganden SDF-1α, bilden diese ein vielversprechendes therapeutisches Ziel für bestimmte Muskelerkrankungen. / The chemokine, SDF-1α, and its receptor, CXCR4, are assumed to control a multitude of biological processes such as organogenesis, haematopoesis, and immune responses. The previous demonstration that SDF-1α additionally binds to the chemokine receptor, CXCR7, currently urges a re-evaluation of the function of the SDF-1 system in these processes. In fact, depending on the tissue and cell type, CXCR7 either acts as a scavenger receptor, a modulator of CXCR4 or an independent active receptor. This thesis is dedicated to answer the following questions: Are both SDF-1α receptors expressed during muscle development? What is the actual function of these receptors during myogenesis? Is there a role of the SDF-1 system in muscle regeneration? To adress these issues both in vitro studies with the myoblast cell line, C2C12, as well as in vivo analyses on the expression of CXCR4, CXCR7 and SDF-1α in developing and regenerating limb muscles have been performed. At all stages of differentiation, C2C12 cells exhibited measurable amounts of CXCR4. In addition, in the course of differentiation C2C12 cells showed increasing expression levels of CXCR7. Treatment of the cells with SDF-1α resulted in the phosphorylation of Erk1/2 and PKCζ/λ and subsequently blocked their myogenic differentiation. Following inactivation of CXCR4 either by its antagonist, AMD3100, or by specific siRNA, SDF-1α failed to activate both pathways and in addition no longer inhibited the myogenic differentiation of C2C12 cells. By contrast, inactivation of CXCR7 remained without effects on SDF-1α-induced cell signalling and resulting inhibitory effects on myogenic differentiation. Interestingly, SDF-1α also failed to activate Erk1/2 signalling in differentiated C2C12 cells. Cell signalling in differentiated C2C12 cells was, however, restored following inhibition of CXCR7 expression, but not following inhibition of CXCR4 expression. The in vivo analysis further revealed that in limb muscles expression of the CXCR4 is highest during embryonic development with a decrease in expression levels shortly after birth when secondary muscle development is completed. Vice versa, expression levels of CXCR7 increased perinatally and remained high into adulthood. In summary, these findings unravel that CXCR4 actively mediates SDF-1α-signalling during myogenesis. The findings further provide evidence that CXCR7 acts as a scavenger receptor during myogenesis which controls myogenic differentiation by modulating extracellular SDF-1α concentration. In further agreement with a major role of SDF-1α in muscle development, SDF-1α is continously expressed by the endomysium of postnatal and adult muscle fibers. Moreover, expression of SDF-1α as well as CXCR4 is massively increased in muscles of dystrophin-deficient mice further implying that the SDF-1 system plays an equally important role during muscle development and regeneration. The pivotal role of SDF-1α in muscle development and regeneration points to the SDF-1 system as a promising therapeutical target for certain muscle diseases.

A rapid cascade of regulatory events defines the differentiated fates of embryonic cells, however, once established, these differentiated fates and the underlying transcriptional programs can be remarkably stable. Here, we describe two proteins, MEP-1, a novel protein, and LET-418/Mi-2, both of which are required for the maintenance of somatic differentiation in C. elegans. MEP-1 was identified as an interactor of PIE-1, a germ-specific protein required for germ cell specification, while LET-418 is a protein homologous to Mi-2, a core component of the nuc1eosome remodeling/histone deacetylase (NuRD) complex. In animals lacking MEP-1 and LET-418, germline-specific genes become derepressed in somatic cells, and Polycomb group (PcG) and SET domain-related proteins promote this ectopic expression. We demonstrate that PIE-1 forms a complex with MEP-1, LET-418, and HDA-1. Furthermore, we show that the overexpression of PIE-1 can mimic the mep-1/let-418 phenotype, and that PIE-1 can inhibit the Histone deacetylase activity of the HDA-1 complex in COS cells. Our findings support a model in which PIE-1 transiently inhibits MEP-1 and associated factors to maintain the pluripotency of germ cells, while at later times MEP-1 and LET-418 remodel chromatin to establish new stage- or cell-type-specific differentiation potential.

Asymmetric cell divisions constitute a basic foundation of animal development, providing a mechanism for placing specific cell types at defined positions in a developing organism. In a 4-cell stage embryo in Caenorhabditis elegansthe EMS cell divides asymmetrically to specify intestinal cells, which requires a polarizing signal from the neighboring P2 cell. Here we describe how the extracellular signal from P2 is transmitted from the membrane to the nucleus during asymmetric EMS cell division, and present the identification of additional components in the pathways that accomplish this signaling. P2/EMS signaling involves multiple inputs, which impinge on the Wnt, MAPK-like, and Src pathways. Transcriptional outputs downstream of these pathways depend on a homolog of β-catenin, WRM-1. Here we analyze the regulation of WRM-1, and show that the MAPK-like pathway maintains WRM-1 at the membrane, while its release and nuclear translocation depend on Wnt/Src signaling and sequential phosphorylation events by the major cell-cycle regulator CDK-1 and by the membrane-bound GSK-3 during EMS cell division. Our results provide novel mechanistic insights into how the signaling events at the cortex are coupled to the asymmetric EMS cell division through WRM-1. To identify additional regulators in the pathways governing gut specification, we performed suppressor genetic screens using temperature-sensitive alleles of the gutless mutant mom-2/Wnt, and extra-gut mutant cks-1. Five intragenic suppressors and three semi-dominant suppressors were isolated in mom-2 suppressor screens. One extragenic suppressor was mapped to the locus ifg-1, eukaryotic translation initiation factor eIF4G. From the suppressor screen using cks-1(ne549), an allele of the self-cleaving nucleopore protein npp-10 was identified as a suppressor of cks-1(ne549)and other extra-gut mutants. Taken together, these results help us better understand how the fate of intestinal cells are specified and regulated in early C. elegans embryos and broaden our knowledge of cell polarity and fate specification.

Der induzierbare Kostimulator ICOS ist ein zu CD28 strukturell und funktionell verwandtes Molekül, das eine wichtige regulatorische Rolle bei der T-Zelleffektorfunktion spielt. Eine ICOS-Defizienz beim Mensch manifestiert sich in einer schweren Störung des humoralen Immunsystems. Eine murine ICOS-Defizienz führt ebenfalls zu einer Beeinträchtigung der T-Zell-abhängigen humoralen Immunantwort, bei der kleinere oder komplett fehlende Keimzentren zu beobachten sind. Vielfältige in vitro und in vivo Studien führten diese Phänomene auf die beeinträchtigte Regulation von Kommunikationsmolekülen der Zelloberfläche und der Zytokinexpression durch ICOS-defiziente T-Zellen zurück. Ein Ziel dieser Arbeit war es, mit Hilfe von ICOS KO Mäusen den Einfluss von ICOS auf die B-Zellentwicklung genauer zu untersuchen. Dabei konnte gezeigt werden, dass ICOS erst in der späten Phase der B-Zellentwicklung eine Rolle spielt, da der Interaktionspartner von ICOS erst auf transitionellen B-Zellen der Milz exprimiert wird. Durch die Etablierung eines in vivo adoptiven T-B Transfermodells konnte die Rolle von ICOS erstmalig bei der T-B Kooperation in den frühen Phasen der Immunantwort auf der Ebene Antigen-spezifischer T- und B-Zellen aufgeklärt werden. Dabei konnte beobachtet werden, dass eine ICOS-Defizienz einen dramatischen Einfluss auf die B-Zellexpansion und B-Zellproliferation hat. Zum ersten Mal konnte in vivo gezeigt werden, dass ICOS bei der T-B Kooperation eine entscheidende Rolle bei der Regulation diverser Oberflächenmarker der B-Zellen spielt, wodurch die B-Zellaktivierung, B-Zellproliferation und B-Zelldifferenzierung bei der Keimzentrums- und Plasmazellreaktion beeinflusst werden. Histologische Analysen zeigten, dass bei einer ICOS-Defizienz follikuläre T-Helferzellen nicht in die Keimzentrumsumgebung einwandern und daher keine T-Zellhilfe für die B-Zellen anbieten können. Dadurch kann die Keimzentrumsreaktion nicht weiter aufrechterhalten werden und eine Ausbildung von kleineren Keimzentren ist die Folge. Weiterhin konnte beobachtet werden, dass eine fehlende ICOS-Interaktion zwischen T- und B-Zellen zu einer Störung der Plasmazellgenerierung führt, wodurch auch die Mengen an messbaren Serumimmunglobulinen beeinflusst werden. Eine erhöhte Gabe von ICOS-defizienten T-Zellen kann diese Effekte nicht vollständig ausgleichen. Daher ist erkennbar, dass ICOS eine Vielzahl von zusätzlichen Faktoren beeinflusst, die für die ICOS-abhängigen B-Zelleffekte verantwortlich sind. / The inducible costimulator ICOS, structural and functional similar to CD28, plays an important regulatory role in T cell receptor function. The ICOS deficiency in humans is described as a severe dysfunction of the humoral immune response, resulting in dramatic reduced B cell numbers and impaired antibody response against pathogens. The murine ICOS-deficiency also leads to a disturbed T cell dependent immune response resulting in a reduced germinal center formation. Various in vitro and in vivo studies attributes this phenomenon to impaired upregulation of cell surface communication molecules and cytokine synthesis by ICOS-deficient T cells. In this work the investigations with ICOS KO mice should clarify the impact of ICOS in B cell development. As observed, ICOS can only play a role in the late phase B cell development, because the interaction partner is expressed on transitional B cells in the spleen. The establishment of an in vivo adoptive T-B transfer system could determine for the first time the role of ICOS in T-B cooperation in early immune response stages on antigen specific T and B cell levels. As shown, ICOS deficiency influences in a dramatic extend the B cell expansion and B cell proliferation. For the first time in vivo, we could demonstrate that ICOS plays a significant role by influencing the regulation of various B cell surface markers, which affects the B cell activation, B cell proliferation and B differentiation in germinal center or plasma cell reaction. Histological investigations revealed in the ICOS-deficiency that follicular T helper cells could not migrate into the germinal center microenvironment and therefore could not provide T cell help for B cells. As a result, the germinal center reaction could not maintained and therefore the formation of little germinal centers occurred. The missing interaction between T and B cells leads to a dysfunction in plasma cell generation and also influences the detectable amounts of serum immunglobulines. An administration of higher ICOS KO T cell numbers could not fully compensate these effects. Therefore, ICOS bias multitudes of additional factors, which are responsible for the ICOS dependent B cell effects.

T-Helfer(Th)-Lymphozyten spielen aufgrund ihrer Expression von Zytokinen eine zentrale Rolle in der Regulation von Immunantworten. Durch die Zytokine fördern die Th-Zellen die Rekrutierung und Aktivierung von Zellen des angeborenen Immunsystems, den Immunglobulin-Klassenwechsel von B-Zellen und ihre Differenzierung zu antikörper-sezernierenden Plasmazellen. Welche Zytokine eine aktivierte Th-Zelle exprimiert hängt von instruktiven Signalen ab, die sie in der Regel von antigen-präsentierenden Signalen bekommt. Mit den instruktiven Signalen wird ein ganzes Differenzierungsprogramm in den Th-Zellen initiiert, welches am Ende zu einer epigenetischen Prägung des Effektorprogramms führt, sodass die Th-Zelle auch bei nachfolgenden Aktivierungen die gleichen Funktionen ausführt. In dieser Arbeit wurde untersucht wie diese Differenzierungsprogramme zur Pathogenese von chronischen Entzündungen beitragen und wie eine chronische Entzündung wiederum die Differenzierung der Th-Zellen beeinflusst. Des Weiteren haben wir molekulare Adaptationen identifiziert, die selektiv in chronisch aktivierten entzündungsfördernden Th Typ 1 (Th1)-Zellen hochgeregelt werden. Diese Adaptationen, wie die Expression von Twist1 und Hopx, fördern das Überleben der Th1-Zellen am Ort der Entzündung und könnten zur Perpetuation der Entzündung entscheidend beitragen. Zusammengenommen zeigen unsere Daten, dass Th-Zellen durch ihre pro-inflammatorische Prägung zwar gut gerüstet sind uns gegen Pathogene zu schützen, im Falle einer Autoreaktivität aber auch Immunpathologie und chronische Entzündungen auslösen können. Allerdings weisen unsere Arbeiten auch daraufhin, dass selektive Anpassungen der Th-Zellen an eine chronische Entzündung auch gleichzeitig Ansatzpunkte für ein therapeutisches Eingreifen bei chronisch-entzündlichen Krankheiten darstellen. / T helper (Th) lymhocytes play a central role in the regulation of immune responses. Through the expression of cytokines, Th cells orchestrate the recruitment and activation of cells of the innate immune system, and induce antibody class switch recombination in B lymphocytes and their differentiation into antibody-secreting plasma cells. Which cytokines an activated Th cell expresses is dependent on instructive signals, the Th cells receives from antigen-presenting cells. Such instructive signals initiate a differentiation program, which in the end leads to the epigenetic imprinting of the effector program, ensuring that the Th cell execute the same functions in subsequent activations. In this thesis, we investigated how such differentiation programs contribute to the pathogenesis of chronic inflammation and how chronic inflammation, in turn, affects the differentiation of the Th cells. Furthermore, we have identified molecular adaptations, which are selectively upregulated in chronically activated pro-inflammatory Th type 1 (Th1) cells. Such adaptations, like the upregulation of Twist1 and Hopx, promote the survival of Th1 cells in the inflamed tissue and could thereby contribute to the perpetuation of the inflammation. Taken together, our data show that Th cells with a pro-inflammatory imprint are well equipped to protect us against pathogens, in case of autoimmunity, however, cause immune pathology and chronic inflammation. At the same time, our work also shows that the selective adaptations of Th cells to chronic inflammation could also be promising targets for novel therapies for the treatment of chronic inflammatory diseases.